中國聯通(0762.HK)高開6.51% 擬與騰訊創投新設合營企業
格隆匯11月3日丨昨日下午A股市場的中國聯通漲停,由於港股下午暫停交易,港股的中國聯通今早高開6.51%報3.6港元。消息面上,中國聯通下屬子公司聯通創投擬與騰訊創投新設合營企業,主要從事內容分發網絡(CDN)和邊緣計算業務。中國聯通晚間發公吿解釋稱,該合營企業的組建正在推進過程中,尚未完成設立登記,對本公司當前生產經營無重大影響,長遠看有利於放大雙方優勢,壯大CDN、邊緣計算產業鏈。騰訊是本公司的長期戰略投資者之一,該事項為本公司與騰訊開展的正常業務合作。另外,接近中國聯通人士的人士評論稱,聯通與騰訊設立混改新公司,不涉及母公司股權變更。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.